Rohan Palekar's Net Worth

$8.22 Million

Estimate Recalculated Nov 4, 2024 02:39AM EST

Who is Rohan Palekar

Rohan Palekar has an estimated net worth of $8.22 Million. This is based on reported shares across multiple companies, which include 89bio, Inc., Neurogene Inc., AVANIR PHARMACEUTICALS, INC., and MEDIVATION, INC..

SEC CIK

Rohan Palekar's CIK is 0001423327

Past Insider Trading and Trends

2022 was Rohan Palekar's most active year for acquiring shares with 8 total transactions. Rohan Palekar's most active month to acquire stocks was the month of January. 2009 was Rohan Palekar's most active year for disposing of shares, totalling 10 transactions. Rohan Palekar's most active month to dispose stocks was the month of August. 2010 saw Rohan Palekar paying a total of $223,645.00 for 81,666 shares, this is the most they've acquired in one year. In 2010 Rohan Palekar cashed out on 30,000 shares for a total of $587,825.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

89bio, Inc.

Chief Executive Officer
Updated Aug 19, 2024
Form 4
-1.00%
-4.60K
$8.04
-$36.99K
Aug 19, 2024
456.24K
Tax
Aug 17
Form 4
-8.34%
-52.72K
$6.42
-$526.90K
Apr 03, 2024
579.40K
Sale
Apr 01
Form 4
-0.91%
-4.48K
$10.76
-$48.17K
Feb 28, 2024
486.89K
Sale
Feb 26
Form 4
-0.93%
-4.60K
$9.74
-$44.82K
Feb 23, 2024
491.37K
Tax
Feb 17
Form 4
-2.57%
-12.67K
$8.45
-$107.06K
Feb 13, 2024
480.97K
Tax
Feb 09
Form 4
215.06%
749.93K
$9.80
-$49.67K
Feb 05, 2024
1.10M
Grant
Feb 01 - Feb 05
Form 4
15.77%
47.49K
$11.53
-$317.20K
Jan 08, 2024
348.71K
Grant
Jan 05
Form 4
-10.07%
-50.00K
$6.57
-$463.50K
Jan 03, 2024
446.46K
Sale
Dec 29
Form 4
-1.47%
-4.50K
$15.46
-$69.59K
Aug 21, 2023
300.95K
Tax
Aug 17
Form 4
5.82%
16.81K
$18.95
-$313.19K
Jul 05, 2023
305.45K
Grant
Jun 30
Form 4
-3.02%
-15.00K
$10.97
-$271.05K
Jun 07, 2023
482.21K
Sale
Jun 05
Form 4
6.65%
17.89K
$15.23
-$235.20K
Apr 04, 2023
286.97K
Grant
Mar 31
Form 4
-5.28%
-15.00K
$16.00
-$240.00K
Mar 27, 2023
269.08K
Sale
Mar 23
Form 4
-2.16%
-6.28K
$13.97
-$87.72K
Feb 22, 2023
284.07K
Tax
Feb 17
Form 4
174.13%
375.00K
Feb 13, 2023
590.35K
Grant
Feb 09
Form 4
-1.86%
-4.08K
$13.24
-$53.99K
Feb 07, 2023
215.35K
Tax
Feb 05
Form 4
11.03%
21.81K
$5.76
-$66.40K
Sep 30, 2022
219.43K
Grant
Sep 28
Form 4
$1.93
$193.00K
Sep 09, 2022
422.85K
Options
Sep 08
Form 4
-4.09%
-4.09K
$5.23
-$21.38K
Apr 13, 2022
95.96K
Tax
Feb 05
Form 4
598.10%
274.20K
Feb 22, 2022
320.05K
Grant
Feb 17
Form 4
19.56%
7.50K
$7.05
$52.85K
Jan 31, 2022
45.85K
Purchase
Jan 27 - Jan 28
Form 4
23.33%
7.00K
$16.84
$117.85K
Jul 08, 2021
37.00K
Purchase
Jul 07 - Jul 08
Form 4
233.75K
Feb 09, 2021
233.75K
Grant
Feb 05
Form 4
170.00K
Feb 19, 2020
170.00K
Grant
Feb 14
Form 3
Nov 08, 2019
Showing 25 results

Neurogene Inc.

Investor
Updated Jun 17, 2024
Form 4
7.70K
Jun 17, 2024
7.70K
Grant
Jun 14
Form 4
15.40K
Jan 18, 2024
15.40K
Grant
Jan 16
Form 4
25.00K
Jun 09, 2023
25.00K
Grant
Jun 08
Form 4
25.00K
May 16, 2022
25.00K
Grant
May 12
Form 4
50.00K
Mar 04, 2022
50.00K
Grant
Mar 02
Form 3
Mar 04, 2022
Showing 6 results

AVANIR PHARMACEUTICALS, INC.

SVP & Chief Commercial Officer
Updated Nov 28, 2014
Form 4
-5.28%
-30.00K
$15.00
-$225.00K
Nov 28, 2014
537.81K
Sale
ScheduledNov 28
Form 4
42.04%
94.06K
Nov 12, 2014
317.81K
Grant
Nov 10
Form 4
-6.00%
-50.00K
$11.25
-$287.50K
Sep 17, 2014
783.50K
Sale
ScheduledSep 15
Form 4
86.54%
123.75K
Feb 14, 2014
266.75K
Grant
Feb 12
Form 4
7.52%
10.00K
$2.80
$28.00K
Dec 19, 2013
143.00K
Purchase
Dec 17
Form 4
47.50K
Dec 17, 2013
47.50K
Grant
Dec 13
Form 4
8.13%
10.00K
$4.19
$41.90K
Nov 05, 2013
133.00K
Purchase
Nov 04
Form 4
198.75%
119.25K
Dec 19, 2012
179.25K
Grant
Dec 17
Form 4
20.00%
10.00K
$2.46
$24.60K
Dec 17, 2012
60.00K
Purchase
Dec 13
Form 4
325.00K
Nov 02, 2012
325.00K
Grant
Apr 03
Form 3
Mar 26, 2012
Showing 11 results

MEDIVATION, INC.

Chief Commercial Officer
Updated Apr 21, 2011
Form 4
-4.56%
-12.50K
$19.17
-$86.45K
Apr 21, 2011
261.67K
Sale
ScheduledApr 20
Form 4
-31.04%
-7.50K
$16.05
-$120.37K
Mar 22, 2011
16.67K
Sale
ScheduledMar 21
Form 4
888.88%
66.67K
Dec 17, 2010
74.17K
Grant
Dec 15
Form 4
50.00%
2.50K
$10.91
$27.27K
May 18, 2010
7.50K
s
ScheduledMay 17
Form 4
-6.14%
-17.50K
$24.65
-$391.45K
Feb 03, 2010
267.50K
Sale
ScheduledFeb 01
Form 4
75.00K
Dec 17, 2009
75.00K
Grant
Dec 15
Form 4
-4.04%
-12.00K
$24.49
-$242.14K
Dec 08, 2009
285.00K
Sale
ScheduledDec 07
Form 4
-6.20%
-19.15K
$19.63
-$266.00K
Sep 11, 2009
297.00K
Sale
ScheduledSep 09 - Sep 10
Form 4
-3.74%
-12.00K
$18.96
-$109.47K
Jul 02, 2009
309.00K
Sale
ScheduledJun 30
Form 4
-32.26%
-10.00K
$16.30
-$163.00K
Mar 19, 2009
21.00K
Sale
ScheduledMar 18
Form 4
75.00K
Nov 03, 2008
75.00K
Grant
Oct 31
Form 4
330.00K
Jan 16, 2008
331.00K
Grant
Jan 14 - Jan 15
Form 3
Jan 16, 2008
1.00K
Showing 13 results